Abstract
Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19.
Highlights
Point-of-care (POC) serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), detect the human antibody response to infection or vaccination and not the virus itself
Serology POC tests for COVID-19 are not recommended for use as a diagnostic tool for acute infection and only three products are approved by Health Canada to date
Most POC serology tests are unable to differentiate. It can take at least [7–14] days, and sometimes longer, after antibodies developed from previous infection from those symptom onset for antibodies to develop, the use generated in response to COVID-19 vaccination
Summary
Suggested citation: Respiratory Virus Infections Working Group. Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Canada communicable disease report = Releve des maladies transmissibles au Canada
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
